Obesity and Cancer in Asia

Chapter
Part of the Energy Balance and Cancer book series (EBAC, volume 2)

Abstract

Obesity has emerged as a major public health challenge for both developed and developing countries. Like more developed countries where obesity represents an increasingly important risk factor for many cancers [1, 2], numerous studies conducted in Asian countries suggest that long-term positive energy balance that leads to elevated adiposity also contributes to the development of many chronic diseases, including the burden associated with a number of different cancer types [3–12]. While the biological mechanisms linking elevated adiposity to cancer do not appear to be markedly different in these populations, there are several unique features of the obesity–cancer association in Asia that are important to understand in relation to cancer prevention and control. First, given the population size and age structure of the larger countries in Asia, the impact of these countries on the worldwide cancer burden is now substantial and in future years will only increase. Second, there are differences in the body size and composition of Asian as compared to Caucasian adults that translate to important differences in association between obesity and cancer, relative to findings from studies conducted among Caucasian adults in the West. In this chapter we will focus on several of these features through review of the epidemiologic evidence available from selected countries in East (e.g., China, Japan, Korea, and Singapore) and Southern Asia (e.g., India, Pakistan).

Keywords

Obesity Hepatitis Lymphoma Estrogen Leukemia 

References

  1. 1.
    International Agency for Research on Cancer. (2002). Weight Control and Physical Activity. Lyon: International Agency for Research on Cancer.Google Scholar
  2. 2.
    Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med, 348:1625–1638.PubMedCrossRefGoogle Scholar
  3. 3.
    Shu XO, Brinton LA, Zheng W, Swanson CA, Hatch MC, Gao YT et al. (1992). Relation of obesity and body fat distribution to endometrial cancer in Shanghai, China. Cancer Res, 52:3865–3870.PubMedGoogle Scholar
  4. 4.
    Kono S, Handa K, Hayabuchi H, Kiyohara C, Inoue H, Marugame T et al. (1999). Obesity, weight gain and risk of colon adenomas in Japanese men. Jpn J Cancer Res, 90:805–811.PubMedCrossRefGoogle Scholar
  5. 5.
    Tung HT, Tsukuma H, Tanaka H, Kinoshita N, Koyama Y, Ajiki W et al. (1999). Risk factors for breast cancer in Japan, with special attention to anthropometric measurements and reproductive history. Jpn J Clin Onco, 29:137–146.CrossRefGoogle Scholar
  6. 6.
    Shu XO, Jin F, Dai Q, Shi JR, Potter JD, Brinton LA et al. (2001). Association of body size and fat distribution with risk of breast cancer among Chinese women. Int J Cancer, 94:449–455.PubMedCrossRefGoogle Scholar
  7. 7.
    Kuriyama S, Tsubono Y, Hozawa A, Shimazu T, Suzuki Y, Koizumi Y et al. (2005). Obesity and risk of cancer in Japan. Int J Cancer, 113:148–157.PubMedCrossRefGoogle Scholar
  8. 8.
    Xu WH, Matthews CE, Xiang YB, Zheng W, Ruan ZX, Cheng JR et al. (2005). Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women. Am J Epidemiol, 161:939–47.PubMedCrossRefGoogle Scholar
  9. 9.
    Oh SW, Yoon YS, Shin SA (2005). Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol, 23:4742–4754.PubMedCrossRefGoogle Scholar
  10. 10.
    Hou L, Ji BT, Blair A, Dai Q, Gao YT, Potter JD et al. (2006). Body mass index and colon cancer risk in Chinese people: Menopause as an effect modifier. European J Cancer, 42:84–90.CrossRefGoogle Scholar
  11. 11.
    Isomura K, Kono S, Moore MA, Toyomura K, Nagano J, Mizoue T et al. (2006). Physical activity and colorectal cancer: the Fukuoka colorectal cancer study. Cancer Sci, 97:1099–1104.PubMedCrossRefGoogle Scholar
  12. 12.
    Jee SH, Yun JE, Park EJ, Cho ER, Park IS, Sull JW et al. (2008). Body mass index and cancer risk in Korean men and women. Int J Cancer, 123:1892–1896.PubMedCrossRefGoogle Scholar
  13. 13.
    Garcia M, Jemal A, Ward K. D, Cerhan JR, Hara K, Siegmund B, Thun MJ (2007). Global Cancer Facts & Figures 2007. Atlanta, GA, American Cancer Society.Google Scholar
  14. 14.
    Pham TM, Fujino Y, Ide R, Tokui N, Kubo T, Mizoue T et al. (2009). Years of life lost due to cancer in a cohort study in Japan. Eur J Public Health, 19:189–192.PubMedCrossRefGoogle Scholar
  15. 15.
    Kim SG, Hahm MI, Choi KS, Seung NY, Shin HR, Park EC (2008). The economic burden of cancer in Korea in 2002. Eur J Cancer Care, 17(2):136–44.CrossRefGoogle Scholar
  16. 16.
    Wang L, Kong L, Wu F, Bai Y, Burton R (2005). Preventing chronic diseases in China. Lancet, 366:1821–1824.PubMedCrossRefGoogle Scholar
  17. 17.
    Joshi R, Cardona M, Iyengar S, Sukumar A, Raju CR, Raju KR et al. (2006). Chronic diseases now a leading cause of death in rural India – mortality data from the Andhra Pradesh rural health initiative. IntJEpidemiol, 35:1522–1529.CrossRefGoogle Scholar
  18. 18.
    Statistics Division, United Nations Economic and Social Commission for Asia and the Pacific UNESCAP (2006). Asia and the Pacific in figures 2006.Google Scholar
  19. 19.
    Jin F, Devesa SS, Chow WH, Zheng W, Ji BT, Fraumeni JF, Jr. et al. (1999). Cancer incidence trends in urban shanghai, 1972–1994: an update. Int J Cancer 83:435–440.PubMedCrossRefGoogle Scholar
  20. 20.
    Katanoda K, Yako-Suketomo H (2009). Comparison of time trends in stomach cancer incidence (1973–2002) in Asia, from Cancer Incidence in Five Continents, Vols IV–IX. Jpn J Clin Oncol, 39:71–72.PubMedCrossRefGoogle Scholar
  21. 21.
    Yako-Suketomo H, Marugame T (2009). Comparison of time trends in colon, rectum and anus cancer incidence (1973–2002) in Asia, from ‘Cancer Incidence in Five Continents, Vols IV–IX’. Jpn J Clin Oncol, 39:196–198.PubMedCrossRefGoogle Scholar
  22. 22.
    Shanghai Municipal Center for Disease Control & Prevention (2006). Shanghai Cancer Report.Google Scholar
  23. 23.
    Shanghai Municipal Center for Disease Control & Prevention (2007). Shanghai Cancer Report.Google Scholar
  24. 24.
    Ji BT, Devesa SS, Chow WH, Jin F, Gao YT (1998). Colorectal cancer incidence trends by subsite in urban Shanghai, 1972–1994. Cancer Epidemiol Biomarkers Prev, 7:661–666.PubMedGoogle Scholar
  25. 25.
    Ke L (2002). Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970–90. Int J Cancer, 102:271–274.PubMedCrossRefGoogle Scholar
  26. 26.
    Yang L, Parkin DM, Li L, Chen Y (2003). Time trends in cancer mortality in China: 1987–1999. Int J Cancer, 106:771–783.PubMedCrossRefGoogle Scholar
  27. 27.
    Fernandes ML, Seow A, Chan YH, Ho KY. (2006). Opposing trends in incidence of esophageal squamous cell carcinoma and adenocarcinoma in a multi-ethnic Asian country. Am J Gastroenterol, 101:1430–1436.PubMedCrossRefGoogle Scholar
  28. 28.
    Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL et al. (1998). Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst, 90:150–155.PubMedCrossRefGoogle Scholar
  29. 29.
    Zhang H, Chen SH, Li YM (2004). Epidemiological investigation of esophageal carcinoma. World J Gastroenterol, 10:1834–1835.PubMedGoogle Scholar
  30. 30.
    Zhou Y, Zhang Z, Zhang Z, Wu J, Ren D, Yan X et al. (2008). A rising trend of gastric cardia cancer in Gansu Province of China. Cancer Lett, 269:18–25.PubMedCrossRefGoogle Scholar
  31. 31.
    London WT, Mcglynn KA (1996). Liver Cancer. In Schottenfeld D, Fraumeni JR (eds.), Cancer Epidemiology and Prevention, pp. 772–793. New York: Oxford University Press.Google Scholar
  32. 32.
    Lee CL, Hsieh KS, Ko YC (2003). Trends in the incidence of hepatocellular carcinoma in boys and girls in Taiwan after large-scale hepatitis B vaccination. Cancer Epidemiol Biomarkers Prev, 12:57–59.PubMedGoogle Scholar
  33. 33.
    Shetty PS (2002). Nutrition transition in India. Public Health Nutr, 5(1A):175–182.PubMedCrossRefGoogle Scholar
  34. 34.
    Popkin BM, Horton S, Kim S, Mahal A, Shuigao J, Popkin BM et al. (2001). Trends in diet, nutritional status, and diet-related noncommunicable diseases in China and India: the economic costs of the nutrition transition. [Review] [58 refs]. Nutr Rev, 59:379–390.PubMedCrossRefGoogle Scholar
  35. 35.
    Popkin BM (2001). The nutrition transition and obesity in the developing world. J Nutr, 131:871S–3S.PubMedGoogle Scholar
  36. 36.
    Ferlay J, Bray F, Pisani P, Parkin DM (2004). GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No.5 Lyon. IARC Press.Google Scholar
  37. 37.
    Bellisari A (2008). Evolutionary origins of obesity. Obes Rev, 9:165–180.PubMedCrossRefGoogle Scholar
  38. 38.
    Yu H, Harris RE, Gao YT, Gao R, Wynder EL (1991). Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. Int J Epidemiol, 20:76–81.PubMedCrossRefGoogle Scholar
  39. 39.
    Popkin BM, Du S (2003). Dynamics of the nutrition transition toward the animal foods sector in China and its implications: a worried perspective. J Nutr, 133:3898S–906S.PubMedGoogle Scholar
  40. 40.
    Griffiths PL, Bentley ME (2001). The nutrition transition is underway in India. J Nutr, 131:2692–2700.PubMedGoogle Scholar
  41. 41.
    Ministry of Health Labour and Welfare (2004). The National Nutrition Survey in Japan, 2002 (in Japanese). Tokyo: Daiichi-Shuppan.Google Scholar
  42. 42.
    Kim S, Moon S, Popkin BM (2000). The nutrition transition in South Korea. Am J Clin Nutr, 71:44–53.PubMedGoogle Scholar
  43. 43.
    Ng SW, Norton EC, Popkin BM (2009). Why have physical activity levels declined among Chinese adults? Findings from the 1991–2006 China health and nutrition surveys. Soc Sci Med, 68:1305–1314.PubMedCrossRefGoogle Scholar
  44. 44.
    Yadav K, Krishnan A (2008). Changing patterns of diet, physical activity and obesity among urban, rural and slum populations in north India. Obes Rev, 9:400–408.PubMedCrossRefGoogle Scholar
  45. 45.
    World Health Organization (2003). Global Strategy on Diet, Physical Activity and Health.Google Scholar
  46. 46.
    Ke-You G, Da-Wei F (2001). The magnitude and trends of under- and over-nutrition in Asian countries. Biomed Environ Sci, 14:53–60.PubMedGoogle Scholar
  47. 47.
    Zheng W, Chow WH, Yang G, Jin F, Rothman N., Blair A. et al. (2005). The Shanghai Women’s Health Study: Rationale, study design, and baseline characteristics (2005). Am J Epidemiol, 162:1123–1131.Google Scholar
  48. 48.
    Lee SA, Xu WH, Zheng W, Li H, Yang G, Xiang YB et al. (2007). Physical activity patterns and their correlates among Chinese men in Shanghai. Med Sci Sports Exerc, 39:1700–1707.PubMedCrossRefGoogle Scholar
  49. 49.
    Department of Women and Child Development (1998). India Nutrition Profile. New Dehli: Government of India, Ministry of Human Resource Development.Google Scholar
  50. 50.
    Gopalan C (1998). Obesity in the urban middle class. Nutr Found India Bull, 19:1–4.Google Scholar
  51. 51.
    Yoshiike N, Seino F, Tajima S, Arai Y, Kawano M, Furuhata T et al. (2002). Twenty-year changes in the prevalence of overweight in Japanese adults: the National Nutrition Survey 1976–95. Obes Rev, 3:183–190.PubMedCrossRefGoogle Scholar
  52. 52.
    Ministry of Health and Welfare (1999). National Health and Nutrition Survey 1998 Korea.Google Scholar
  53. 53.
    Ministry of Health and Welfare (2002). National Health and Nutrition Survey 2001 Korea.Google Scholar
  54. 54.
    World Health Organization (1998). Obesity: Preventing and Managing the Global Epidemic. Geneva, Switzerland: WHO.Google Scholar
  55. 55.
    van der KK, Leenen R, Seidell JC, Deurenberg P, Droop A, Bakker CJ (1993). Waist-hip ratio is a poor predictor of changes in visceral fat. Am J Clin Nutr, 57:327–333.Google Scholar
  56. 56.
    Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A et al. (1994). Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol, 73:460–468.PubMedCrossRefGoogle Scholar
  57. 57.
    Xu WH, Matthews CE, Xiang YB, Zheng W, Ruan ZX, Cheng JR et al. (2005). Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women. Am J Epidemiol, 161:939–947.PubMedCrossRefGoogle Scholar
  58. 58.
    Deurenberg P, Deurenberg YM, Wang J, Lin FP, Schmidt G (1999). The impact of body build on the relationship between body mass index and percent body fat. Int J Obes Relat Metab Disord, 23:537–542.PubMedCrossRefGoogle Scholar
  59. 59.
    Deurenberg P, urenberg-Yap M, Guricci S. (2002). Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev, 3:141–146.PubMedCrossRefGoogle Scholar
  60. 60.
    Rush EC, Freitas I, Plank LD (2009). Body size, body composition and fat distribution: comparative analysis of European, Maori, Pacific Island and Asian Indian adults. Br J Nutr, 1–10.Google Scholar
  61. 61.
    Kagawa M, Kerr D, Uchida H, Binns CW (2006). Differences in the relationship between BMI and percentage body fat between Japanese and Australian-Caucasian young men. Br J Nutr, 95:1002–1007.PubMedCrossRefGoogle Scholar
  62. 62.
    Oh SW, Shin SA, Yun YH, Yoo T, Huh BY (2004). Cut-off point of BMI and obesity-related comorbidities and mortality in middle-aged Koreans. Obes Res, 12:2031–2040.PubMedCrossRefGoogle Scholar
  63. 63.
    Wen CP, vid Cheng TY, Tsai SP, Chan HT, Hsu HL, Hsu CC et al. (2009). Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutr, 12:497–506.PubMedCrossRefGoogle Scholar
  64. 64.
    Zhou BF (2002). Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults – study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci, 15:83–96.PubMedGoogle Scholar
  65. 65.
    World Health Organization (2000). International Association for the Study of Obesity & International Obesity Task Force. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Health Communications.Google Scholar
  66. 66.
    Inoue M, Okayama A, Fujita M, Enomoto T, Tanizawa O, Ueshima HA (1994). Case-control study on risk factors for uterine endometrial cancer in Japan. Jpn J Cancer Res, 85: 346–350.PubMedCrossRefGoogle Scholar
  67. 67.
    Iemura A, Douchi T, Yamamoto S, Yoshimitsu N, Nagata Y (2000). Body fat distribution as a risk factor of endometrial cancer. J Obstet Gynaecol Res, 26:421–425PubMedCrossRefGoogle Scholar
  68. 68.
    Ng EH, Gao F, Ji CY, Ho GH, Soo KC (1997). Risk factors for breast carcinoma in Singaporean Chinese women: the role of central obesity. Cancer, 80:725–731.PubMedCrossRefGoogle Scholar
  69. 69.
    Shu XO, Jin F, Dai Q, Shi JR, Potter JD, Brinton LA et al. (2001). Association of body size and fat distribution with risk of breast cancer among Chinese women. Int J Cancer, 94:449–455.PubMedCrossRefGoogle Scholar
  70. 70.
    Hirose K, Tajima K, Hamajima N, Takezaki T, Inoue M, Kuroishi T et al. (1999). Effect of body size on breast-cancer risk among Japanese women. Int J Cancer, 80:349–355.PubMedCrossRefGoogle Scholar
  71. 71.
    Gilani GM, Kamal S (2004). Risk factors for breast cancer in Pakistani women aged less than 45 years. Ann Hum Biol, 31:398–407PubMedCrossRefGoogle Scholar
  72. 72.
    Mathew A, Gajalakshmi V, Rajan B, Kanimozhi V, Brennan P, Mathew BS et al. (2008). Anthropometric factors and breast cancer risk among urban and rural women in South India: a multicentric case-control study. Br J Cancer, 99:207–213.PubMedCrossRefGoogle Scholar
  73. 73.
    Chow LW, Lui KL, Chan JC, Chan TC, Ho PK, Lee WY et al. (2005). Association between body mass index and risk of formation of breast cancer in Chinese women. Asian J Surg, 28:179–184.PubMedCrossRefGoogle Scholar
  74. 74.
    Demark-Wahnefried W, Peterson BL, Winer EP, Marks L, Aziz N, Marcom PK et al. (2001) Changes in Weight, Body Composition, and Factors Influencing Energy Balance Among Premenopausal Breast Cancer Patients Receiving Adjuvant Chemotherapy. J Clin Oncol, 19:2381–2389.PubMedGoogle Scholar
  75. 75.
    Han HS, Lee KW, Kim JH, Kim SW, Kim IA, Oh DY et al. (2009). Weight changes after adjuvant treatment in Korean women with early breast cancer. Breast Cancer Res Treat,114(1):147–153.PubMedCrossRefGoogle Scholar
  76. 76.
    Wu MH, Chou YC, Yu JC, Yu CP, Wu CC, Chu CM et al. (2006). Hormonal and body-size factors in relation to breast cancer risk: a prospective study of 11,889 women in a low-incidence area. Ann Epidemiol, 16:223–229.PubMedCrossRefGoogle Scholar
  77. 77.
    Sonnenschein E, Toniolo P, Terry MB, Bruning PF, Kato I, Koenig KL et al. (1999). Body fat distribution and obesity in pre- and postmenopausal breast cancer. Int J Epidemiol, 28:1026–1031.PubMedCrossRefGoogle Scholar
  78. 78.
    Harvie M, Hooper L, Howell AH (2003). Central obesity and breast cancer risk: a systematic review. Obes Rev, 4(3):157–173.PubMedCrossRefGoogle Scholar
  79. 79.
    Oh SW, Yoon YS, Shin SA (2005). Effects of Excess Weight on Cancer Incidences Depending on Cancer Sites and Histologic Findings Among Men: Korea National Health Insurance Corporation Study. J Clin Oncol, 23:4742–4754.PubMedCrossRefGoogle Scholar
  80. 80.
    Tamakoshi K, Wakai K, Kojima M, Watanabe Y, Hayakawa N, Toyoshima H et al. (2004). A prospective study of body size and colon cancer mortality in Japan: The JACC Study. International Journal of Obesity & Related Metabolic Disorders: J Intl Assoc Study Obes, 28(4):551–558.CrossRefGoogle Scholar
  81. 81.
    Song YM, Sung J, Ha M (2008). Obesity and risk of cancer in postmenopausal Korean women. J Clin Oncol, 26:3395–3402.PubMedCrossRefGoogle Scholar
  82. 82.
    Oh TH, Byeon JS, Myung SJ, Yang SK, Choi KS, Chung JW et al. (2008). Visceral obesity as a risk factor for colorectal neoplasm. J Gastroenterol Hepatol 23:411–417.PubMedCrossRefGoogle Scholar
  83. 83.
    Otake S, Takeda H, Suzuki Y, Fukui T, Watanabe S, Ishihama K et al. (2005). Association of Visceral Fat Accumulation and Plasma Adiponectin with Colorectal Adenoma: Evidence for Participation of Insulin Resistance. Clin Cancer Res, 11:3642–3646.PubMedCrossRefGoogle Scholar
  84. 84.
    Kim JH, Lim YJ, Kim YH, Sung IK, Shim SG, Oh SO et al. (2007). Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev, 16:1543–1546.PubMedCrossRefGoogle Scholar
  85. 85.
    Kim Y, Kim Y, Lee S (2009). An association between colonic adenoma and abdominal obesity: a cross-sectional study. BMC Gastroenterol, 9:4.PubMedCrossRefGoogle Scholar
  86. 86.
    Hsing AW, Deng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Benichou J et al. (2000). Body size and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev, 9:1335–1341.PubMedGoogle Scholar
  87. 87.
    Zhang M, Xie X, Holman CD (2005). Body weight and body mass index and ovarian cancer risk: a case-control study in China. Gynecol Oncol, 98:228–234.PubMedCrossRefGoogle Scholar
  88. 88.
    Niwa Y, Yatsuya H, Tamakoshi K, Nishio K, Kondo T, Lin Y et al. (2005). Relationship between body mass index and the risk of ovarian cancer in the Japanese population: findings from the Japanese Collaborate Cohort (JACC) study. J Obstet Gynaecol Res 31:452–458.PubMedCrossRefGoogle Scholar
  89. 89.
    Mori M, Nishida T, Sugiyama T, Komai K, Yakushiji M, Fukuda K et al. (1998). Anthropometric and other risk factors for ovarian cancer in a case-control study. Jpn J Cancer Res, 89:246–253.PubMedCrossRefGoogle Scholar
  90. 90.
    Ji BT, Hatch MC, Chow WH, McLaughlin JK, Dai Q, Howe GR et al. (1996). Anthropometric and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai, China. Int J Cancer, 66:432–437PubMedCrossRefGoogle Scholar
  91. 91.
    Lin Y, Kikuchi S, Tamakoshi A, Yagyu K, Obata Y, Inaba Y et al. (2007). Obesity, physical activity and the risk of pancreatic cancer in a large Japanese cohort. Int J Cancer, 120:2665–2671PubMedCrossRefGoogle Scholar
  92. 92.
    Yun JE, Jo I, Park J, Kim MT, Ryu HG, Odongua N et al. (2006). Cigarette smoking, elevated fasting serum glucose, and risk of pancreatic cancer in Korean men. Int J Cancer, 119:208–212PubMedCrossRefGoogle Scholar
  93. 93.
    Ansary-Moghaddam A, Huxley R, Barzi F, Lawes C, Ohkubo T, Fang X et al. (2006). The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-Pacific region. Cancer Epidemiol Biomarkers Prev, 15:2435–2440PubMedCrossRefGoogle Scholar
  94. 94.
    Hsing AW, Sakoda LC, Rashid A, Chen J, Shen MC, Han TQ et al. (2008). Body size and the risk of biliary tract cancer: a population-based study in China. Br J Cancer, 99:811–815PubMedCrossRefGoogle Scholar
  95. 95.
    Brown LM, Swanson CA, Gridley G, Swanson GM, Schoenberg JB, Greenberg RS et al. (1995). Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst, 87:104–109PubMedCrossRefGoogle Scholar
  96. 96.
    Vaughan TL, Davis S, Kristal A, Thomas DB (1995). Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev, 4:85–92PubMedGoogle Scholar
  97. 97.
    Guo W, Blot WJ, Li JY, Taylor PR, Liu BQ, Wang W et al. (1994). A nested case-control study of oesophageal and stomach cancers in the Linxian nutrition intervention trial. Int J Epidemiol, 23:444–450PubMedCrossRefGoogle Scholar
  98. 98.
    Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, Dong ZW et al. (2005). Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer, 113:456–463PubMedCrossRefGoogle Scholar
  99. 99.
    Smith M, Zhou M, Whitlock G, Yang G, Offer A, Hui G et al. (2008). Esophageal cancer and body mass index: results from a prospective study of 220,000 men in China and a meta-analysis of published studies. Int J Cancer, 122:1604–1610PubMedCrossRefGoogle Scholar
  100. 100.
    Ji BT, Chow WH, Yang G, McLaughlin JK, Gao RN, Zheng W et al. (1997) Body mass index and the risk of cancers of the gastric cardia and distal stomach in Shanghai, China. Cancer Epidemiol Biomarkers Prev, 6:481–485PubMedGoogle Scholar
  101. 101.
    Zhang J, Su XQ, Wu XJ, Liu YH, Wang H, Zong XN et al. (2003). Effect of body mass index on adenocarcinoma of gastric cardia. World J Gastroenterol, 9:2658–2661PubMedGoogle Scholar
  102. 102.
    Awakura Y, Nakamura E, Ito N, Yamasaki T, Kamba T, Kamoto T et al. (2007). Influence of body mass index on prognosis of Japanese patients with renal cell carcinoma. Urology, 70:50–54.PubMedCrossRefGoogle Scholar
  103. 103.
    Jonsson F, Wolk A, Pedersen NL, Lichtenstein P, Terry P, Ahlbom A et al. (2003). Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer, 106:594–599PubMedCrossRefGoogle Scholar
  104. 104.
    Guilera M, Connelly-Frost A, Keku TO, Martin CF, Galanko J, Sandler RS (2005). Does physical activity modify the association between body mass index and colorectal adenomas? Nutr Cancer, 51:140–145PubMedCrossRefGoogle Scholar
  105. 105.
    Wen W, Cai Q, Xiang YB, Xu WH, Ruan ZX, Cheng J et al. (2008). The modifying effect of C-reactive protein gene polymorphisms on the association between central obesity and endometrial cancer risk. Cancer, 112:2409–2416PubMedCrossRefGoogle Scholar
  106. 106.
    Sherman B, Wallace R, Bean J (1983). Estrogen use and breast cancer. Interaction with body mass. Cancer, 51(8):1527–1531.PubMedCrossRefGoogle Scholar
  107. 107.
    Kim S, Baron JA, Mott LA, Burke CA, Church TR, Keown-Eyssen GE et al. (2006). Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States). Cancer Causes Control, 17:1299–1304.PubMedCrossRefGoogle Scholar
  108. 108.
    Dai Q, Franke AA, Yu H, Shu XO, Jin F, Hebert JR et al. (2003). Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics. Cancer Epidemiol Biomarkers Prev, 12:497–502.PubMedGoogle Scholar
  109. 109.
    Dai Q, Gao Y-T, Shu XO, Yang G, Milne G, Cai Q et al. (2009). Oxidative stress, Obesity, and Breast Cancer Risk: Results from the Shanghai Women’s Health Study (SWHS). J Clin Oncol, (in press).Google Scholar
  110. 110.
    Slattery ML, Murtaugh MA, Quesenberry C, Caan BJ, Edwards S, Sweeney C (2007). Changing population characteristics, effect-measure modification, and cancer risk factor identification. Epidemiol Perspect Innov, 4:10.PubMedCrossRefGoogle Scholar
  111. 111.
    Berclaz G, Li S, Price KN, Coates AS, Castiglione-Gertsch M, Rudenstam CM et al. (2004). Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol, 15(6):875–884.PubMedCrossRefGoogle Scholar
  112. 112.
    Tao MH, Shu XO, Ruan ZX, Gao YT, Zheng W, Tao MH et al. (2006). Association of overweight with breast cancer survival. Am J Epidemiol 163:101–7.PubMedCrossRefGoogle Scholar
  113. 113.
    Kyogoku S, Hirohata T, Takeshita S, Nomura Y, Shigematsu T, Horie A (1990). Survival of breast-cancer patients and body size indicators. Intl J Cancer, 46(5):824–831.CrossRefGoogle Scholar
  114. 114.
    Moon HG, Ju YT, Jeong CY, Jung EJ, Lee YJ, Hong SC et al. (2008). Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol, 15(7): 1918–1922.PubMedCrossRefGoogle Scholar
  115. 115.
    Park SM, Lim MK, Shin SA, Yun YH (2006). Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National health insurance corporation study. J Clin Oncol, 24:5017–5024.PubMedCrossRefGoogle Scholar
  116. 116.
    Moriwaki Y, Kunisaki C, Kobayashi S, Harada H, Imai S, Kasaoka C (2003). Does body mass index (BMI) influence morbidity and long-term survival in gastric cancer patients after gastrectomy? Hepatogastroenterology, 50:284–8.PubMedGoogle Scholar
  117. 117.
    Gunter MJ, Leitzmann MF (2006). Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J Nutr Biochem, 17:145–156PubMedCrossRefGoogle Scholar
  118. 118.
    Algul H, Treiber M, Lesina M, Schmid RM (2007). Mechanisms of disease: chronic inflammation and cancer in the pancreas – a potential role for pancreatic stellate cells? Nat Clin Pract Gastroenterol Hepatol, 4:454–462.PubMedCrossRefGoogle Scholar
  119. 119.
    Nishida M, Moriyama T, Sugita Y, Yamauchi-Takihara K (2007). Abdominal obesity exhibits distinct effect on inflammatory and anti-inflammatory proteins in apparently healthy Japanese men. Cardiovasc Diabetol, 6:27.PubMedCrossRefGoogle Scholar
  120. 120.
    Liu J, Zhai X, Jin G, Hu Z, Wang S, Wang X et al. (2006). Functional variants in the promoter of interleukin-1beta are associated with an increased risk of breast cancer: a case-control analysis in a Chinese population. Int J Cancer, 118:2554–8.PubMedCrossRefGoogle Scholar
  121. 121.
    Chiu HM, Lin JT, Chen TH, Lee YC, Chiu YH, Liang JT et al. (2008). Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men. Am J Gastroenterol, 103:2317–2235PubMedCrossRefGoogle Scholar
  122. 122.
    Li CQ, Pignatelli B, Ohshima H (2000). Coexpression of interleukin-8 and inducible nitric oxide synthase in gastric mucosa infected with cagA+ Helicobacter pylori. Dig Dis Sci, 45:55–62.PubMedCrossRefGoogle Scholar
  123. 123.
    Hankinson SE, Willett WC, Manson JE, Hunter DJ, Colditz GA, Stampfer MJ et al. (1995). Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst, 87:1297–1302.PubMedCrossRefGoogle Scholar
  124. 124.
    Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K (2000). Relations of insulin resistance and serum concentrations of estradiol and sex hormone-binding globulin to potential breast cancer risk factors. Jpn J Cancer Res, 91:948–953PubMedCrossRefGoogle Scholar
  125. 125.
    Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C et al. (2003). Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst, 95:1218–1226.PubMedCrossRefGoogle Scholar
  126. 126.
    Kaaks R, Lukanova A, Kurzer MS. (2002). Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev, 11:1531–1543.PubMedGoogle Scholar
  127. 127.
    Suga K, Imai K, Eguchi H, Hayashi S, Higashi Y, Nakachi K (2001). Molecular significance of excess body weight in postmenopausal breast cancer patients, in relation to expression of insulin-like growth factor I receptor and insulin-like growth factor II genes. Jpn J Cancer Res, 92:127–134.PubMedCrossRefGoogle Scholar
  128. 128.
    Yu H, Jin F, Shu XO, Li BD, Dai Q, Cheng JR et al. (2002). Insulin-like growth factors and breast cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev, 11:705–712.PubMedGoogle Scholar
  129. 129.
    Fair AM, Dai Q, Shu XO, Matthews CE, Yu H, Jin F et al. (2007). Energy balance, insulin resistance biomarkers, and breast cancer risk. Cancer Detect Prev, 31:214–9.PubMedCrossRefGoogle Scholar
  130. 130.
    Berrington de GA, Yun JE, Lee SY, Klein AP, Jee SH (2008). Pancreatic cancer and factors associated with the insulin resistance syndrome in the Korean cancer prevention study. Cancer Epidemiol Biomarkers Prev, 17:359–364.CrossRefGoogle Scholar
  131. 131.
    Hsing AW, Gao YT, Chua S Jr, Deng J, Stanczyk FZ (2003). Insulin resistance and prostate cancer risk. J Natl Cancer Inst, 95:67–71.PubMedCrossRefGoogle Scholar
  132. 132.
    Yang G, Lu G, Jin F, Dai Q, Best R, Shu XO et al. (2001). Population-based, case-control study of blood C-peptide level and breast cancer risk. Cancer Epidemiol, Biomarkers Prev, 10:1207–1211.Google Scholar
  133. 133.
    Calle EE,Kaaks R (2004). Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579–591.PubMedCrossRefGoogle Scholar
  134. 134.
    Mayne ST,Navarro SA (2002). Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans. J Nutr 132:3467S–3470S.PubMedGoogle Scholar
  135. 135.
    Corley DA, Kubo A, Levin TR, Block G, Habel L, Zhao W et al. (2007). Abdominal obesity and body mass index as risk factors for Barrett’s esophagus. Gastroenterology, 133:34–41.PubMedCrossRefGoogle Scholar
  136. 136.
    Okabayashi T, Gotoda T, Kondo H, Inui T, Ono H, Saito D et al. (2000). Early carcinoma of the gastric cardia in Japan: is it different from that in the West? Cancer 89:2555–9.PubMedCrossRefGoogle Scholar
  137. 137.
    Kendall BJ, Macdonald GA, Hayward NK, Prins JB, Brown I, Walker N et al. (2008). Leptin and the risk of Barrett’s oesophagus. Gut, 57:448–454.PubMedCrossRefGoogle Scholar
  138. 138.
    Whiteman DC, Sadeghi S, Pandeya N, Smithers BM, Gotley DC, Bain CJ et al. (2008). Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut, 57:173–180.PubMedCrossRefGoogle Scholar
  139. 139.
    Clark JM (2006). The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol, 40:S5–10.PubMedGoogle Scholar
  140. 140.
    El-Serag HB,Rudolph KL (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132:2557–2576.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Epidemiology, School of Public HealthFudan UniversityShanghaiChina
  2. 2.Division of Cancer Epidemiology and GeneticsNational Cancer InstituteRockvilleUSA

Personalised recommendations